Carlos-Alberto Calderon-Ospina (C A Calderon-Ospina, Carlos A Calderon-Ospina, Carlos Alberto Calderon-Ospina, Carlos Alberto Calderón-Ospina)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

Biomedicines

Therapeutic advances in drug safety

International journal of molecular sciences

Therapeutics and clinical risk management

Universidad Del Rosario

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Del Rosario

Colombia

Profesor Principal :: Escuela de Medicina y Ciencias de la Salud

Publications

Carlos-Alberto Calderon-Ospina
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance. Therapeutic advances in drug safety 14 (2023)
Daniela Baracaldo-Santamaría, Sara Sofia Avendaño-Lopez, Daniel Felipe Ariza-Salamanca, Mateo Rodriguez-Giraldo, Carlos-Alberto Calderon-Ospina, Rodrigo E González-Reyes, Mauricio Orlando Nava-Mesa
Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer's Disease. International journal of molecular sciences 24 (10) (2023)
María Gabriela Corrales-Hernández, Sebastián Kurt Villarroel-Hagemann, Isabella Esther Mendoza-Rodelo, Leonardo Palacios-Sánchez, Mariana Gaviria-Carrillo, Natalia Buitrago-Ricaurte, Santiago Espinosa-Lugo, Carlos-Alberto Calderon-Ospina, Jesús Hernán Rodríguez
Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence. Biomedicines 11 (6) (2023)
Daniela Baracaldo-Santamaría, John Edwin Feliciano-Alfonso, Raul Ramirez-Grueso, Luis Carlos Rojas-Rodríguez, Camilo Alberto Dominguez-Dominguez, Carlos-Alberto Calderon-Ospina
Making Sense of Composite Endpoints in Clinical Research. Journal of clinical medicine 12 (13) (2023)
María Gabriela Corrales-Hernández, Sebastián Kurt Villarroel-Hagemann, Isabella Esther Mendoza-Rodelo, Leonardo Palacios-Sánchez, Mariana Gaviria-Carrillo, Natalia Buitrago-Ricaurte, Santiago Espinosa-Lugo, Carlos-Alberto Calderon-Ospina, Jesús Hernán Rodríguez
Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence. Biomedicines 11 (6) (2023)
Ana María Paez-Hurtado, Carlos-Alberto Calderon-Ospina, Mauricio Orlando Nava-Mesa
Mechanisms of action of vitamin B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) in pain: a narrative review. Nutritional neuroscience (2022)
Daniela Baracaldo-Santamaría, Daniel Felipe Ariza-Salamanca, María Gabriela Corrales-Hernández, Maria José Pachón-Londoño, Isabella Hernandez-Duarte, Carlos-Alberto Calderon-Ospina
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside. Pharmaceutics 14 (1) (2022)
Alberto Navarro, Ingrid Casallas, Daniel Isaza, Paola Ortiz, Daniela Baracaldo-Santamaría, Carlos-Alberto Calderon-Ospina
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity. Medicina (Kaunas, Lithuania) 58 (7) (2022)
Daniela Baracaldo-Santamaría, Maria José Trujillo-Moreno, Andrés M Pérez-Acosta, John Edwin Feliciano-Alfonso, Carlos-Alberto Calderon-Ospina, Franklin Soler
Definition of self-medication: a scoping review. Therapeutic advances in drug safety 13 (2022)
Daniela Baracaldo-Santamaría, María Gabriela Corrales-Hernández, Maria Camila Ortiz-Vergara, Valeria Cormane-Alfaro, Ricardo Miguel Luque-Bernal, Carlos-Alberto Calderon-Ospina, Juan-Fernando Cediel-Becerra
Connexins and Pannexins: Important Players in Neurodevelopment, Neurological Diseases, and Potential Therapeutics. Biomedicines 10 (9) (2022)
Daniela Baracaldo-Santamaría, Juan David Cala-García, Germán José Medina-Rincón, Luis Carlos Rojas-Rodriguez, Carlos-Alberto Calderon-Ospina
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation? Antibiotics (Basel, Switzerland) 11 (5) (2022)
Daniela Baracaldo-Santamaría, Carlos-Alberto Calderon-Ospina, Claudia Patricia Ortiz, Rossember Edén Cardenas-Torres, Fleming Martinez, Daniel Ricardo Delgado
Thermodynamic Analysis of the Solubility of Isoniazid in (PEG 200 + Water) Cosolvent Mixtures from 278.15 K to 318.15 K. International journal of molecular sciences 23 (17) (2022)
Maria Jose Nino-Orrego, Daniela Baracaldo-Santamaría, Claudia Patricia Ortiz, Heyde Patricia Zuluaga, Sthefany Alejandra Cruz-Becerra, Franklin Soler, Andrés M Pérez-Acosta, Daniel Ricardo Delgado, Carlos-Alberto Calderon-Ospina
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study. Therapeutic advances in drug safety 13 (2022)
Daniela Baracaldo-Santamaría, Kevin Llinás-Caballero, Julián Miguel Corso-Ramirez, Carlos Martin Restrepo, Camilo Alberto Dominguez-Dominguez, Dora Janeth Fonseca Mendoza, Carlos-Alberto Calderon-Ospina
Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation. International journal of molecular sciences 22 (15) (2021)
Mariana Angulo-Aguado, Karen Panche, Caroll Andrea Tamayo-Agudelo, Daniel-Armando Ruiz-Torres, Santiago Sambracos-Parrado, Maria Jose Niño-Orrego, Nathaly Páez, Laura B Piñeros-Hernandez, Luisa-Fernanda Castillo-León, Juan Mauricio Pardo-Oviedo, Katherine Parra Abaunza, Paul Laissue, Nora Contreras, Carlos-Alberto Calderon-Ospina, Dora Janeth Fonseca-Mendoza
A Pharmacogenetic Study of CYP2C19 in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy. Journal of personalized medicine 11 (5) (2021)
Carlos-Alberto Calderon-Ospina, Mauricio Orlando Nava-Mesa, Ana María Paez-Hurtado
Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review. Therapeutics and clinical risk management 16 (2020)
Carlos-Alberto Calderon-Ospina, Mario Hernández-Sómerson, Ana María García, Adriana Mejia, Caroll Tamayo-Agudelo, Paul Laissue, Dora Janeth Fonseca Mendoza
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions. Pharmacogenomics and personalized medicine 13 (2020)

Carlos-Alberto Calderon-Ospina.css-eqlu8i{font-size:small;padding-left:4px;} (C A Calderon-Ospina, Carlos A Calderon-Ospina, Carlos Alberto Calderon-Ospina, Carlos Alberto Calderón-Ospina)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos-Alberto Calderon-Ospina (C A Calderon-Ospina, Carlos A Calderon-Ospina, Carlos Alberto Calderon-Ospina, Carlos Alberto Calderón-Ospina)